1.
Pan Afr Med J
; 21: 140, 2015.
Article
in French
| MEDLINE
| ID: mdl-26327977
Subject(s)
Delivery, Obstetric/statistics & numerical data , Pregnancy Complications, Cardiovascular/epidemiology , Pregnancy Outcome , Adult , Female , Humans , Infant, Newborn , Intensive Care Units, Neonatal/statistics & numerical data , Maternal Health Services , Pregnancy , Pregnancy Complications, Cardiovascular/physiopathology , Retrospective Studies , Tunisia/epidemiology , Young Adult
2.
Case Rep Obstet Gynecol
; 2012: 248564, 2012.
Article
in English
| MEDLINE
| ID: mdl-22567525
ABSTRACT
Cesarean scar pregnancy is a rare type of ectopic pregnancy associated with severe complications such as uterine rupture, uncontrollable bleeding which may lead to hysterectomy, and definitive infertility. Many therapeutic options are available such as Dilatation & Curetage, excision of trophoblastic tissues using either laparotomy or laparoscopy, systemically administered Methotrexate, and more recently uterine artery embolization. The use of Methotrexate sometimes required laparotomy later because of severe hemorrhage. Through this paper, we demonstrated that viable cesarean scar pregnancy can be managed safely by systemically delivered Methotrexate at the cost of a prolonged followup.